By Dr Deepu
The CBS Evening News (7/10, story 6, 1:35, Pelley) reported in continuing coverage on the FDA’s new “warning about common pain relievers.” According to the broadcast, “the FDA says everyone may be at risk, but the biggest concerns are for people with an underlying heart condition.”
The Washington Post (7/11, Cha) reported that the warning updates will apply to “nonsteroidal anti-inflammatory drugs (NSAIDs), a group of medications used for temporary relief of pain and inflammation,” and that include ibuprofen and naproxen. The article added that “consumers should be careful not to take more than one product that contains an NSAID at a time” and to watch for symptoms such as “chest pain, breathing trouble, sudden weakness in one part or side of the body or slurred speech.”
No comments:
Post a Comment
Please leave your comments